Apogee Therapeutics Inc (NASDAQ:APGE) currently has a daily average trading volume of 867.49K but it saw 1300259 shares traded in last market. With a market cap of 2.30B USD, the company’s current market price of $38.57 came rising about 4.19 while comparing to the previous closing price of $37.02. In past 52 weeks, the stock remained buoying in the range of price level as high as $63.50 and as low as $26.20. In the recent trading on the day, stock has struck highest price mark of $36.45 while lowest mark touched by it was $39.3283.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the BTIG Research which reiterated the stock as “Buy” in its note to investors issued on July 07, 2025, recommending a price target of between $100 and $115 for it. Canaccord Genuity issued its recommendations for the stock as it initiated the price target for the stock is $89.
Over the week, APGE’s stock price is moving -12.97% down while it is -3.89% when we observe its performance for the past one month. Year-to-date it is -2.60% down and over the past year, the stock is showing a downside performance of -14.86%.
The company is expected to be releasing its next quarterly report on 2025-May-12, for which analysts forecasted an EPS of -1.03 while estimate for next year EPS is -4.3.
Currently, Apogee Therapeutics Inc’s total number of outstanding shares is 46.04M with 7.62% of that held by the insiders while 137.71% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -30.15% and return on equity (ROE) at -27.85%. Stock’s beta reads 1.51. Stock has a price to book (P/B) ratio of 3.41. Its return on asset (ROA) is -26.71% on average.
